FeesSafety
Pluang+

Fortive boosts recurring revenue with service plans and software subscriptions at Fluke and healthcare segments

Market News
15 Sep 2026
Seeking Alpha
View Source
Bullish
Fortive boosts recurring revenue with service plans and software subscriptions at Fluke and healthcare segments

Fortive Corporation highlights strong growth in recurring revenue through hardware-as-a-service and software subscriptions, especially at its Fluke brand and healthcare segments. The company is enhancing customer experience by attaching service plans and subscription software to products, increasing utilization of healthcare sterilization equipment. Recent FDA approval allowing higher weight capacity on sterilization machines enables more device processing, driving consumables and service sales. Fortive focuses on deepening value with its existing 100,000 customers to fuel future growth.

Fortive Corporation's recent presentation at Morgan Stanley's 14th Annual Laguna Conference comes as 36 of 75 Industrials-sector US stocks tradable on Pluang rose while 38 fell. For readers following Industrials, here is Pluang's market snapshot as of Sep 16, 2026 03:03 WIB: C.H. Robinson Worldwide, Inc. (CHRW) rose 2.76% to USD 157.00, Emerson Electric Co. (EMR) fell 2.47% to USD 148.40, and American Airlines Group Inc (AAL) dropped 2.44% to USD 12.78.

More News

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...

Company Fundamentals
Bullish
4 hours ago
Solana outperforms XRP with higher transactions and stablecoin use, boosting optimism for its price.

Solana outperforms XRP with higher transactions and stablecoin use, boosting optimism for its price.

Motley Fool's recent analysis highlights Solana's stronger network activity compared to XRP, with Solana processing 3.18 billion transactions in September 2026 versus XRP's 222.4 million in Q2 2026. Solana also supports a larger stablecoin supply of ...

Market News
Bullish
4 hours ago
XRP Ledger holds $641M in real-world assets, far behind Ethereum's $16B total

XRP Ledger holds $641M in real-world assets, far behind Ethereum's $16B total

As of October 24, the XRP Ledger had $641.17 million in distributed real-world assets, significantly less than Ethereum's $16.05 billion and other blockchains like BNB Chain, Solana, and Stellar. The XRP Ledger tracked 451 assets excluding stablecoin...

Protocol Fundamentals
Neutral
4 hours ago
South Korea's KOSPI falls 2.8% amid global market de-risking and bond market vulnerabilities.

South Korea's KOSPI falls 2.8% amid global market de-risking and bond market vulnerabilities.

South Korea's tech-heavy KOSPI index dropped 2.8% with major stocks Samsung and SK Hynix falling sharply. This decline reflects a broader global trend of de-risking and deleveraging, especially in highly leveraged European and U.S. bond markets, whic...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App